Thorne Zinc Picolinate 30 mg Review

30 mg is the dose Prasad 1996 (PMID 8875519) used for 6 months in marginally zinc-deficient men to near-double serum testosterone. It also sits cleanly inside Cervantes 2019's acne RCT range (30-50 mg) and below the 40 mg/day Tolerable Upper Intake Level for chronic dosing. For most buyers running an 8-12 week deficiency repletion protocol, 30 mg/day is the right call. Higher doses (50 mg via Nutricost #5) are appropriate for short-term aggressive repletion in verified-deficient adults but require copper co-supplementation past week 6 — at chronic 50 mg/day, copper depletion becomes a real risk. Drop to 15 mg/day maintenance once serum zinc retests in-range.

The molecule is functionally equivalent — both are top-tier chelates at 30 mg elemental per cap. The premium ($5/month) buys you NSF Certified for Sport on every batch: each lot tested against 270+ WADA-banned substances at an NSF-accredited lab. For drug-tested athletes (NCAA, IOC, MLB, NFL, NHL, MLS) it's non-negotiable. For recreational lifters it's a fraud filter you pay for and don't directly use — but the mineral-supplement category has a real heavy-metals contamination history (lead in zinc gluconate lozenges in the late 2000s, cadmium in some bulk picolinate batches) and NSF certification meaningfully neutralizes that. For first-time chelate buyers without budget constraints, the certification premium is worth it. For cost-optimisers, NOW Foods is the right call.

Functionally a tie at this dose. Maares & Haase 2020 (PMID 32183116) catalogues both at ~25-30% absorbability — well ahead of oxide (~10%) and gluconate (~15%) but essentially equivalent to each other. Bisglycinate has a slight edge in stomach gentleness for the most-sensitive guts; picolinate has a slight edge in some short-duration absorption trials. At 30 mg elemental with food, neither form will nauseate most users. If you have a history of mineral-supplement GI upset, switch to NOW Foods Zinc Glycinate (#3) for bisglycinate. Otherwise picolinate works cleanly.

12 weeks is the safe upper bound for solo zinc at 30 mg/day; beyond that, add 1-2 mg copper daily to prevent depletion. Zinc competes with copper for the same intestinal transporters, and chronic high-dose zinc gradually depletes serum copper — clinically meaningful at 50+ mg/day within 4-6 weeks, gradual at 30 mg/day over months. Practical protocol on Thorne's 30 mg/day single-cap: run 8-12 weeks of solo dosing, retest serum zinc (and ideally copper too), drop to 15 mg/day maintenance, add copper bisglycinate 1-2 mg/day if continuing past 12 weeks. The Wessells & Brown 2012 deficiency-prevalence model documents who actually needs the chronic protocol versus a one-time 8-week repletion.

Morning with breakfast, ideally containing some protein and fat. Zinc absorption is reduced by phytates (whole grains, legumes) eaten in the same meal — but breakfast is typically the lowest-phytate meal of the day, so co-administration risk is minimal. Avoid taking with coffee or tea (tannins block zinc) and separate from calcium or iron supplements by 2+ hours (they compete for the same transporters). Empty-stomach dosing produces faster GI upset and is associated with nausea reports across the zinc literature. Bedtime dosing works fine pharmacokinetically but offers no specific benefit and complicates the food-pairing requirement. Morning is the right default.

Strongly recommended for the testosterone use case, optional for general immune/skin support. The Prasad 1996 testosterone effect only manifests in marginally zinc-deficient men (serum <70 μg/dL) — replete subjects (>90 μg/dL) showed zero T uplift. A baseline serum zinc test ($30 add-on to your next blood panel) tells you whether you're in the responsive band before committing to a 6-month protocol. For immune and acne endpoints (Hemilä 2017, Cervantes 2019 references), the effect is less deficiency-conditional and you can run the protocol without baseline testing. But the testosterone-specific value proposition fundamentally depends on your starting serum zinc — test before, not after.

1. [1] Prasad 1996 PMID 8875519 — Zinc status and serum testosterone levels of healthy adults. 30 mg/day zinc for 6 months in marginally zinc-deficient men nearly doubled serum testosterone (8.3 → 16.0 nmol/L). Replete subjects showed zero T uplift. The cornerstone trial Thorne's single-cap 30 mg dose was designed around.
2. [2] Maares & Haase 2020 PMID 32183116 — A guide to human zinc absorption: general overview and recent advances of in vitro intestinal models. Form-by-form absorption catalogue: bisglycinate and picolinate consistently outperform sulfate and gluconate at ~25-30% absorbability vs ~10-15% for the inferior forms. Validates Thorne's picolinate choice as one of the two top-tier consumer forms.
3. [3] Cervantes 2019 PMID 29193602 — The role of zinc in the treatment of acne: A review of the literature. Comprehensive review of zinc-in-acne RCTs: 30-50 mg elemental zinc daily matched low-dose oral antibiotic outcomes for inflammatory acne, without antibiotic-resistance risk. Thorne's 30 mg dose sits at the lower bound of the trial range.
4. [4] Hemilä 2017 PMID 28515951 — Zinc acetate lozenges for treating the common cold: an individual patient data meta-analysis. IPD meta-analysis: zinc lozenges started within 24 hours of cold symptom onset at 75-80 mg/day cut cold duration ~33%. Daily tablet protocols like Thorne's address chronic immune baseline, not acute cold duration — the two are different tools.
5. [5] Wessells & Brown 2012 PMID 23209782 — Estimating the global prevalence of zinc deficiency: results based on zinc availability in national food supplies and the prevalence of stunting. Global prevalence model: ~17% of the world population is at risk of inadequate zinc intake. Risk concentrated in plant-based diets where phytate-zinc binding blocks absorption. Establishes the structural-deficiency baseline that Thorne's trial-dose product is designed to repleete.